Consumer Health Cancer / Oncology
Kelun-Biotech's NDA for Sacituzumab Tirumotecan Accepted by China's NMPA Following Positive Lung Cancer Study Results
New drug application (NDA) for the core product sacituzumab tirumotecan (sac-TMT, formerly SKB264/MK-2870) based on the positive results from the pivotal O...
August 21, 2024 | News
Boston Immune Technologies and Therapeutics Secures Strategic Agreement with Otsuka's MSRD and $4M NIH/NCI Grant for Advancing Antibody Development
Boston Immune Technologies and Therapeutics, Inc. (BITT), a clinical stage developer of novel tumor necrosis factor superfamily receptor (TNFSR) antagonist...
August 19, 2024 | News
Akeso’s Ivonescimab Granted Priority Review by China's NMPA for First-Line Treatment of PD-L1 Positive NSCLC
Akeso, Inc. announced that the National Center for Drug Evaluation of the State Drug Administration of the People's Republic of China (NMPA CDE) ...
August 15, 2024 | News
Alfred Health Expands Oracle EHR to Enhance Cancer Care and Clinical Trial Access
Leading Victorian healthcare network, Alfred Health, has extended its long-standing Oracle Health footprint with Oracle's Oncology electroni...
August 14, 2024 | News
Angiex Initiates Patient Dosing in Phase 1 Clinical Trial of AGX101, a First-in-Class TM4SF1-Directed Antibody-Drug Conjugate for Solid Cancers
Angiex, a developer of Nuclear-Delivered Antibody-Drug Conjugate™ (ND-ADC) therapies for solid cancers, announced that patient dosing has begun for t...
August 12, 2024 | News
NEC Bio Therapeutics and AGC Biologics Partner to Enhance Production of Personalized Cancer Vaccine
NEC Bio Therapeutics and AGC Biologics have announced a partnership to advance the production of NECVAX-NEO1, an orally delivered, bacteria-based D...
August 08, 2024 | News
Thermo Fisher's SeCore™ CDx HLA A Sequencing System Gains FDA Clearance for Use with Adaptimmune’s New TCR Therapy
Thermo Fisher Scientific Inc., the world leader in serving science, announced that its SeCore™ CDx HLA A Sequencing System has been granted 510(...
August 07, 2024 | News
NCCN Enhances Partnership with Medlive to Expand Oncology Guidelines Access in China
United States-based National Comprehensive Cancer Network strengthens relationship with Chinese medical platform Medlive to broaden access to eminent oncol...
July 31, 2024 | News
ObvioHealth Secures Strategic Investment from Guardant Health to Boost Oncology Clinical Trials
ObvioHealth, a global digital clinical trials company, announces a new strategic investment by Guardant Health, Inc., a leading precision oncology company ...
July 26, 2024 | News
Pfizer Opens SGD$1 Billion Green Mark Gold-Certified API Manufacturing Facility in Singapore
Invests SGD$1 billion to produce small molecule APIs for oncology, pain, and antibiotic medicines The facility is Green Mark ‘Go...
July 23, 2024 | News
QDX and Prelude Therapeutics Join Forces to Target Previously Undrugged Oncology Targets
QDX, a computational drug discovery company, announced a collaboration with Prelude Therapeutics, a clinical-stage precision oncology company, targeti...
July 23, 2024 | News
Thermo Fisher and NCI Join Forces to Accelerate Precision Medicine Trials for AML and MDS
To help accelerate research into new treatments for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS), Thermo Fisher Scientific Inc. (NYSE: T...
July 12, 2024 | News
N-Power Medicine Partners with MSD to Expand Oncologist and Patient Access to Clinical Trials
N-Power Medicine, a company reinventing the clinical trial process, is collaborating with Merck, known as MSD outside the United States and Canada, to enab...
July 02, 2024 | News
Lilly Forms Strategic Partnership with Radionetics for GPCR-Targeted Radiopharmaceuticals
Provides Lilly access to Radionetics’ proprietary GPCR targeting small molecule radiopharmaceuticals Radionetics to receive $140 million upfront p...
July 02, 2024 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
